Skip to main content

Main menu

  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us

Clinical Medicine Journal

  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

User menu

  • Log in

Search

  • Advanced search
RCP Journals
Home
  • Log in
  • Home
  • Our journals
    • Clinical Medicine
    • Future Healthcare Journal
  • Subject collections
  • About the RCP
  • Contact us
Advanced

Clinical Medicine Journal

clinmedicine Logo
  • ClinMed Home
  • Content
    • Current
    • Ahead of print
    • Archive
  • Author guidance
    • Instructions for authors
    • Submit online
  • About ClinMed
    • Scope
    • Editorial board
    • Policies
    • Information for reviewers
    • Advertising

Influenza-related pneumonia

Fergus Dignan
Download PDF
DOI: https://doi.org/10.7861/clinmedicine.12-3-299a
Clin Med June 2012
Fergus Dignan
Boscombe Down, Salisbury
Roles: Civilian medical practitioner, MOD
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Editor – In regard to the CME Respiratory Medicine article by Almond et al on influenza-related pneumonia (Clin Med February 2012 pp 67–70), I would like to correct a point on when to administer antiviral therapy.

It is stated in the article that based on Department of Health recommendations1 uncomplicated influenza infection should be treated with prompt commencement of antiviral therapy. However, more recent guidelines from the Health Protection Agency2 state that generally in an uncomplicated presentation of influenza, treatment, other than symptomatic, is not required.

While it is correct that in the hospital setting all patients with influenza should be given antiviral drugs such as oseltamivir, in the community those patients with an uncomplicated presentation should only receive antiviral treatment if they have underlying health issues such as chronic heart, liver, pulmonary or renal disease.

Oseltamivir does have potential significant side effects such as nausea, vomiting and abdominal pain, and even reports of more serious adverse effects such as hepatitis, neuropsychiatric disorders and Stevens–Johnson syndrome,3 and so the risk-benefit balance in uncomplicated cases in the community favours not giving it.

  • © 2012 Royal College of Physicians

References

  1. ↵
    1. Department of Health
    (2009) Pandemic H1N1 2009 influenza: clinical management guidelines for adults and children, 2009 (DOH, London).
  2. ↵
    1. Health Protection Agency
    (2011) HPA guidance on use of antiviral agents for the treatment and prophylaxis of influenza, 2011–12 (version 3) (HPA, London).
  3. ↵
    (2011) British National Formulary 62 (BNF, London) 5.3.5, p 408.
Back to top
Previous articleNext article

Article Tools

Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Citation Tools
Influenza-related pneumonia
Fergus Dignan
Clinical Medicine Jun 2012, 12 (3) 299-300; DOI: 10.7861/clinmedicine.12-3-299a

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Influenza-related pneumonia
Fergus Dignan
Clinical Medicine Jun 2012, 12 (3) 299-300; DOI: 10.7861/clinmedicine.12-3-299a
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • References
  • Info & Metrics

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • JAK-inhibition as a therapeutic strategy for refractory primary systemic vasculitides
  • Response
  • Functional disorders and chronic pain
Show more Letters to the editor

Similar Articles

Navigate this Journal

  • Journal Home
  • Current Issue
  • Ahead of Print
  • Archive

Related Links

  • ClinMed - Home
  • FHJ - Home
clinmedicine Footer Logo
  • Home
  • Journals
  • Contact us
  • Advertise
HighWire Press, Inc.

Follow Us:

  • Follow HighWire Origins on Twitter
  • Visit HighWire Origins on Facebook

Copyright © 2021 by the Royal College of Physicians